USD 27.0
(-3.98%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 | 8.34 Million USD | -5.53% |
2023 | 8.13 Million USD | 13.18% |
2022 | 7.19 Million USD | 53.23% |
2021 | 4.69 Million USD | 56.68% |
2020 | 2.99 Million USD | -17.26% |
2019 | 3.62 Million USD | -23.68% |
2018 | 4.74 Million USD | 18.78% |
2017 | 3.99 Million USD | -5.57% |
2016 | 4.22 Million USD | 21.45% |
2015 | 3.48 Million USD | 13.35% |
2014 | 3.07 Million USD | -15.36% |
2013 | 3.62 Million USD | -37.87% |
2012 | 5.84 Million USD | -5.22% |
2011 | 6.16 Million USD | -7.75% |
2010 | 6.68 Million USD | 23.66% |
2009 | 5.4 Million USD | 0.89% |
2008 | 5.35 Million USD | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 FY | 8.34 Million USD | 2.47% |
2024 Q1 | 5.84 Million USD | -28.2% |
2024 Q2 | 6.62 Million USD | 13.31% |
2024 Q3 | 6.35 Million USD | -4.0% |
2024 Q4 | 8.34 Million USD | 20.95% |
2023 Q3 | 6.44 Million USD | 6.67% |
2023 Q2 | 6.04 Million USD | 0.9% |
2023 Q1 | 5.99 Million USD | -16.7% |
2023 Q4 | 8.13 Million USD | 26.24% |
2023 FY | 8.13 Million USD | 13.18% |
2022 Q2 | 4.71 Million USD | -2.92% |
2022 Q4 | 7.19 Million USD | 43.56% |
2022 Q1 | 4.85 Million USD | 3.54% |
2022 FY | 7.19 Million USD | 53.23% |
2022 Q3 | 5 Million USD | 6.19% |
2021 Q3 | 4.29 Million USD | 23.15% |
2021 Q4 | 4.69 Million USD | 9.19% |
2021 Q1 | 3.53 Million USD | 18.01% |
2021 Q2 | 3.48 Million USD | -1.27% |
2021 FY | 4.69 Million USD | 56.68% |
2020 Q4 | 2.99 Million USD | -17.86% |
2020 FY | 2.99 Million USD | -17.26% |
2020 Q3 | 3.64 Million USD | 20.21% |
2020 Q2 | 3.03 Million USD | -8.96% |
2020 Q1 | 3.33 Million USD | -7.97% |
2019 Q1 | 4.48 Million USD | -5.54% |
2019 FY | 3.62 Million USD | -23.68% |
2019 Q4 | 3.62 Million USD | 11.7% |
2019 Q3 | 3.24 Million USD | 5.54% |
2019 Q2 | 3.07 Million USD | -31.45% |
2018 Q4 | 4.74 Million USD | 26.6% |
2018 FY | 4.74 Million USD | 18.78% |
2018 Q3 | 3.74 Million USD | -0.87% |
2018 Q2 | 3.77 Million USD | -1.24% |
2018 Q1 | 3.82 Million USD | -4.16% |
2017 FY | 3.99 Million USD | -5.57% |
2017 Q1 | 3.04 Million USD | -27.98% |
2017 Q2 | 3.47 Million USD | 14.19% |
2017 Q3 | 3.88 Million USD | 11.63% |
2017 Q4 | 3.99 Million USD | 2.86% |
2016 Q4 | 4.22 Million USD | 4.27% |
2016 Q2 | 3.6 Million USD | 8.64% |
2016 FY | 4.22 Million USD | 21.45% |
2016 Q1 | 3.32 Million USD | -4.59% |
2016 Q3 | 4.05 Million USD | 12.38% |
2015 FY | 3.48 Million USD | 13.35% |
2015 Q4 | 3.48 Million USD | 3.9% |
2015 Q3 | 3.35 Million USD | 7.34% |
2015 Q1 | 3.4 Million USD | 10.75% |
2015 Q2 | 3.12 Million USD | -8.23% |
2014 Q2 | 3.98 Million USD | 5.28% |
2014 FY | 3.07 Million USD | -15.36% |
2014 Q4 | 3.07 Million USD | -16.42% |
2014 Q3 | 3.67 Million USD | -7.67% |
2014 Q1 | 3.78 Million USD | 4.18% |
2013 Q3 | 4.54 Million USD | 1.92% |
2013 Q4 | 3.62 Million USD | -20.16% |
2013 FY | 3.62 Million USD | -37.87% |
2013 Q1 | 5.39 Million USD | -7.71% |
2013 Q2 | 4.45 Million USD | -17.26% |
2012 Q3 | 5.6 Million USD | -1.11% |
2012 Q1 | 6.16 Million USD | -0.03% |
2012 FY | 5.84 Million USD | -5.22% |
2012 Q4 | 5.84 Million USD | 4.28% |
2012 Q2 | 5.66 Million USD | -8.07% |
2011 Q2 | 5.57 Million USD | -6.71% |
2011 Q4 | 6.16 Million USD | 13.59% |
2011 Q3 | 5.42 Million USD | -2.65% |
2011 Q1 | 5.97 Million USD | -10.59% |
2011 FY | 6.16 Million USD | -7.75% |
2010 Q4 | 6.68 Million USD | 4.84% |
2010 Q3 | 6.37 Million USD | 0.0% |
2010 FY | 6.68 Million USD | 23.66% |
2009 FY | 5.4 Million USD | 0.89% |
2009 Q4 | 5.4 Million USD | 0.0% |
2008 FY | 5.35 Million USD | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Myomo, Inc. | 5.59 Million USD | -49.136% |
Senseonics Holdings, Inc. | 64.76 Million USD | 87.123% |
Catheter Precision, Inc. | 9.54 Million USD | 12.615% |
Xtant Medical Holdings, Inc. | 41.26 Million USD | 79.788% |